title: Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia.
authors.affiliation: Leukemia Service at Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: Nicole
authors.initials: N
authors.lastname: Lamanna
authors.forename: Mark A
authors.initials: MA
authors.lastname: Weiss